Page last updated: 2024-11-10

mead acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

mead acid: also known as 20:3(n-9) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(5Z,8Z,11Z)-icosatrienoic acid : A 5,8,11-eicosatrienoic acid in which all three double bonds adopt cis-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5312531
CHEMBL ID1865841
CHEBI ID72865
SCHEMBL ID842264
MeSH IDM0056864

Synonyms (60)

Synonym
BRD-K96144918-001-02-3
IDI1_033882
BSPBIO_001412
etre(5z, 8z, 11z)
5z,8z,11z-eicosatrienoic acid
mead acid
LMFA01030381
cis-5,8,11-eicosatrienoic acid, ~10 mg/ml in ethanol, >=90%
c20:3n-9,12,15
NCGC00161346-01
NCGC00161346-02
NCGC00161346-03
HMS1989G14
2751-14-6
cis-5,8,11-eicosatrienoic acid
20590-32-3
mead acid (20:3 n-9)
BML3-B04
HMS1791G14
HMS1361G14
(5z,8z,11z)-icosa-5,8,11-trienoic acid
all-cis-eicosa-5,8,11-trienoic acid
CHEBI:72865 ,
5z,8z,11z-icosatrienoic acid
all-cis-5,8,11-eicosatrienoic acid
(5z,8z,11z)-eicosatrienoic acid
etre(5z,8z,11z)
(5z,8z,11z)-icosatrienoic acid
(5z,8z,11z)-eicosa-5,8,11-trienoic acid
all-cis-icosa-5,8,11-trienoic acid
(z,z,z)-5,8,11-eicosatrienoic acid
FA004
unii-jqs194yh3x
SCHEMBL842264
20:3(n-9)
5,8,11-eicosatrienoic acid, (z,z,z)-
5,8,11-eicosatrienoic acid, (5z,8z,11z)-
JQS194YH3X ,
(5z,8z,11z)-eicosatrienoate
CHEMBL1865841
HMS3649F17
HMS3402G14
mfcd00065719
AKOS030530797
J-013446
mead acid (20:3, n-9)
cis-5,8,11-eicosatrienoate
(z,z,z)-5,8,11-eicosatrienoate
5z,8z,11z-eicosatrienoate
5,8,11-eicosatrienoate
all-cis-5,8,11-eicosatrienoate
DTXSID10920487
Q416610
5(z),8(z),11(z)-eicosatrienoic acid
SR-01000946654-1
sr-01000946654
C21938
HY-108398A
CS-0059639
PD020549

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" A series of dose-response experiments were conducted with albumin-bound fatty acid substrates (18:1n-9 and 20:1n-9) provided in concentrations up to 100µM."( The role of fatty acid desaturase (FADS) genes in oleic acid metabolism: FADS1 Δ7 desaturates 11-20:1 to 7,11-20:2.
Brenna, JT; Engel, MG; Kothapalli, KS; Lawrence, P; Park, HG; Vogt-Lowell, K, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
5,8,11-eicosatrienoic acidAn icosatrienoic acid with three bonds at positions 5, 8 and 11.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Omega-9 fatty acid synthesis226
Elongation of (very) long chain fatty acids345

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
regulator of G-protein signaling 4Homo sapiens (human)Potency0.47440.531815.435837.6858AID504845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (75)

TimeframeStudies, This Drug (%)All Drugs %
pre-199028 (37.33)18.7374
1990's15 (20.00)18.2507
2000's11 (14.67)29.6817
2010's18 (24.00)24.3611
2020's3 (4.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (2.60%)5.53%
Reviews3 (3.90%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (1.30%)0.25%
Other71 (92.21%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]